Global Retirement Partners, LLC Akebia Therapeutics, Inc. Transaction History

Global Retirement Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 09, 2020	SELL	$2.39 - $13.08 $4,741 - $25,950	-1,984 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$6.67 - $13.58 $2,201 - $4,481	330 Added 19.95%	1,984 $27,000
Q1 2020 Apr 28, 2020	BUY	$4.1 - $10.24 $282 - $706	69 Added 4.35%	1,654 $13,000
Q4 2019 Jan 23, 2020	BUY	$3.16 - $6.73 $537 - $1,144	170 Added 12.01%	1,585 $10,000
Q1 2019 May 07, 2019	BUY	$5.41 - $8.73 $2,153 - $3,474	398 Added 39.13%	1,415 $12,000
Q4 2018 Feb 22, 2019	BUY	$5.39 - $9.15 $4,570 - $7,759	848 Added 501.78%	1,017 $6,000
Q2 2018 Aug 13, 2018	BUY	$9.15 - $11.34 $1,546 - $1,916	169 New	169 $2,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.